Boston Scientific Corporation $BSX Stock: Russell Investments Group Ltd. Increases Stake

Russell Investments Group Ltd. grew its stake in Boston Scientific Corporation (NYSE:BSX – Free Report) by 10.8% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 3,207,330 shares of the medical equipment provider’s stock after purchasing an additional 311,634 shares during the period. Russell Investments Group Ltd.’s holdings in Boston Scientific were worth $140,024,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds also recently made changes to their positions in the company. Eurizon Capital SGR S.p.A. increased its stake in shares of Boston Scientific by 31.9% in the third quarter. Eurizon Capital SGR S.p.A. now owns 1,596,301 shares of the medical equipment provider’s stock valued at $69,766,000 after buying an additional 386,008 shares during the period. PBU The Pension Fund of Early Childhood & Youth Educators boosted its holdings in Boston Scientific by 18.8% in the third quarter. PBU The Pension Fund of Early Childhood & Youth Educators now owns 263,677 shares of the medical equipment provider’s stock valued at $11,510,000 after acquiring an additional 41,713 shares during the last quarter. Werba Rubin Papier Wealth Management bought a new stake in Boston Scientific in the third quarter valued at approximately $239,000. R Squared Ltd bought a new stake in Boston Scientific in the third quarter valued at approximately $365,000. Finally, Nan Fung Trinity HK Ltd. acquired a new stake in Boston Scientific during the 3rd quarter valued at approximately $31,777,000. 89.07% of the stock is currently owned by institutional investors and hedge funds.

Boston Scientific Trading Down 0.0%

NYSE:BSX opened at $44.33 on Monday. The company has a debt-to-equity ratio of 0.42, a current ratio of 1.36 and a quick ratio of 0.81. The firm has a 50-day moving average of $44.00 and a 200-day moving average of $54.50. The company has a market cap of $64.25 billion, a PE ratio of 18.78, a PEG ratio of 1.31 and a beta of 0.60. Boston Scientific Corporation has a one year low of $39.57 and a one year high of $104.61.

Boston Scientific (NYSE:BSX – Get Free Report) last announced its quarterly earnings results on Wednesday, October 28th. The medical equipment provider reported $0.73 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.73. Boston Scientific had a return on equity of 18.61% and a net margin of 16.62%. The business had revenue of $5.14 billion during the quarter, compared to the consensus estimate of $5.09 billion. During the same quarter in the prior year, the company posted $0.75 earnings per share. Boston Scientific’s revenue was up 1.4% compared to the same quarter last year. As a group, equities research analysts expect that Boston Scientific Corporation will post 3.17 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities analysts recently weighed in on BSX shares. Deutsche Bank set a $48.00 target price on shares of Boston Scientific and gave the stock a “buy” rating in a research note on Thursday, October 29th. Robert W. Baird upped their price target on shares of Boston Scientific from $50.00 to $51.00 and gave the company an “outperform” rating in a research report on Thursday, October 29th. UBS Group cut their price target on shares of Boston Scientific from $67.00 to $57.00 and set a “buy” rating on the stock in a research report on Thursday, October 29th. Wells Fargo & Company decreased their price target on Boston Scientific from $48.00 to $45.00 and set an “equal weight” rating for the company in a report on Thursday, October 29th. Finally, Mizuho set a $50.00 price objective on Boston Scientific in a research report on Thursday, October 29th. One equities research analyst has rated the stock with a Strong Buy rating, twenty have issued a Buy rating, eight have issued a Hold rating and two have given a Sell rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $61.43.

View Our Latest Research Report on BSX

About Boston Scientific

(Free Report)

Boston Scientific is a medical technology company that develops, manufactures and markets devices used in minimally invasive procedures across a range of medical specialties. Founded in 1979, the company is headquartered in Marlborough, Massachusetts. Its products support areas including cardiovascular care, endoscopy, urology and neuromodulation. They include catheter-based devices and therapies for conditions affecting the heart and blood vessels, as well as devices used in diagnostic and therapeutic procedures involving the digestive and urinary systems.

Featured Articles

Want to see what other hedge funds are holding BSX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Boston Scientific Corporation (NYSE:BSX – Free Report).

Institutional Ownership by Quarter for Boston Scientific (NYSE:BSX)

Receive News & Ratings for Boston Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Boston Scientific and related companies with MarketBeat.com's FREE daily email newsletter.